Pgen stock forecast sector sentiment in biotech remains

Sector sentiment in biotech remains cautiously bullish. Click here to see the full list of 233 stocks from our US High Growth Tech and AI Stocks screener. Multiple analysts have issued price targets for $PGEN recently. We have seen 3 analysts offer price targets for $PGEN in the last 6 months, with a median target of $8.0. PGEN stock forecast updates point to regulatory developments in the gene therapy space, which could add upside risk if FDA guidance becomes favorable. Tracking sector ETFs may provide early signals of broader trend changes.